News
Position ：
- Implantable Sacral Nerve Stimulation System approved for marketing2023-07-14
- Retagliptin Phosphate Tablets approved for marketing by China NMPA2023-07-14
- Multimodal Tumor Treatment System approved for marketing2023-07-13
- Oteseconazole Capsules approved for marketing by China NMPA2023-07-13
- Innovative TCM Shenyu Ningshen Tablet approved for marketing2023-07-11
- Iruplinalkib Tablets approved for marketing by China NMPA2023-07-11
- Vorolanib Tablets approved for marketing by China NMPA2023-07-06
- Pegmolesatide Injection approved for marketing by China NMPA2023-07-06
- Telpegfilgrastim Injection Approved for Marketing by China NMPA2023-07-05
- Equecabtagene Autoleucel Injection approved for marketing by China NMPA2023-07-05